These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

511 related articles for article (PubMed ID: 35955621)

  • 41. In silico study of azithromycin, chloroquine and hydroxychloroquine and their potential mechanisms of action against SARS-CoV-2 infection.
    Braz HLB; Silveira JAM; Marinho AD; de Moraes MEA; Moraes Filho MO; Monteiro HSA; Jorge RJB
    Int J Antimicrob Agents; 2020 Sep; 56(3):106119. PubMed ID: 32738306
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Microneedle array delivered recombinant coronavirus vaccines: Immunogenicity and rapid translational development.
    Kim E; Erdos G; Huang S; Kenniston TW; Balmert SC; Carey CD; Raj VS; Epperly MW; Klimstra WB; Haagmans BL; Korkmaz E; Falo LD; Gambotto A
    EBioMedicine; 2020 May; 55():102743. PubMed ID: 32249203
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A comparison between SARS-CoV-1 and SARS-CoV2: an update on current COVID-19 vaccines.
    Abdolmaleki G; Taheri MA; Paridehpour S; Mohammadi NM; Tabatabaei YA; Mousavi T; Amin M
    Daru; 2022 Dec; 30(2):379-406. PubMed ID: 36050585
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Impact of COVID-19 on male urogenital health: Success of vaccines.
    Kucukyildiz K; Yilmaz-Oral D; Turkcan D; Oztekin CV; Gur S
    Drug Discov Today; 2022 Oct; 27(10):103327. PubMed ID: 35905935
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Thraustochytrid hosts for expression of proteins relevant to SARS-CoV-2 intervention.
    Dahmen J; Vermeulen A; Payne S; Lippmeier C
    PLoS One; 2023; 18(4):e0283592. PubMed ID: 37043472
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A New Wave of COVID-19 in 2021 with Unique Genetic Characters - Present Global Scenario and Beholding Onwards.
    Mukherjee S; Ray SK
    Infect Disord Drug Targets; 2022; 22(6):e010422202932. PubMed ID: 35366784
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [A preview of COVID-19 vaccination and treatment].
    de Boer MGJ; Bonten MJM; Huckriede ALW
    Ned Tijdschr Geneeskd; 2022 May; 166():. PubMed ID: 36036707
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cell Entry and Unusual Replication of SARS-CoV-2.
    McCann N; Castellino FJ
    Curr Drug Targets; 2022; 23(17):1539-1554. PubMed ID: 36239725
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Developing dendritic cell for SARS-CoV-2 vaccine: Breakthrough in the pandemic.
    Jonny J; Putranto TA; Irfon R; Sitepu EC
    Front Immunol; 2022; 13():989685. PubMed ID: 36148241
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Immunophenotyping of SARS-CoV-2 and vaccine design.
    Cimolai N
    Vaccine; 2022 Jun; 40(30):3985-3986. PubMed ID: 35717108
    [No Abstract]   [Full Text] [Related]  

  • 51. Formulation, Device, and Clinical Factors Influencing the Targeted Delivery of COVID-19 Vaccines to the Lungs.
    Mossadeq S; Shah R; Shah V; Bagul M
    AAPS PharmSciTech; 2022 Nov; 24(1):2. PubMed ID: 36416999
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Spike in pollution to ignite the bursting of COVID-19 second wave is more dangerous than spike of SAR-CoV-2 under environmental ignorance in long term: a review.
    Paital B; Das K
    Environ Sci Pollut Res Int; 2022 Dec; 29(57):85595-85611. PubMed ID: 34390474
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A survey of mechanisms underlying current and potential COVID-19 vaccines.
    Hebel C; Thomsen AR
    APMIS; 2023 Feb; 131(2):37-60. PubMed ID: 36394112
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Female reproductive health during the COVID-19 pandemic: latest evidence and understanding.
    Li S; Liu H; Li D; Chen F
    Arch Gynecol Obstet; 2023 Dec; 308(6):1691-1696. PubMed ID: 36856820
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Various aspects of the relationship between vitiligo and the COVID-19 pandemic or SARS-CoV-2 vaccines: Clinical pearls for dermatologists.
    Aryanian Z; Balighi K; Hatami P; Goodarzi A; Janbakhsh A; Afshar ZM
    J Cosmet Dermatol; 2023 Apr; 22(4):1152-1156. PubMed ID: 36762373
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Neurological and neuropsychological adverse effects of SARS-CoV-2 vaccines - where do we stand?
    Aliasin MM; Yazdanpanah N; Rezaei N
    Rev Neurosci; 2022 Oct; 33(7):721-743. PubMed ID: 35334195
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Safety & effectiveness of COVID-19 vaccines: A narrative review.
    Chirico F; Teixeira da Silva JA; Tsigaris P; Sharun K
    Indian J Med Res; 2022 Jan; 155(1):91-104. PubMed ID: 35859436
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The COVID-19 Pandemic: SARS-CoV-2 Structure, Infection, Transmission, Symptomology, and Variants of Concern.
    Guest PC; Kesharwani P; Butler AE; Sahebkar A
    Adv Exp Med Biol; 2023; 1412():3-26. PubMed ID: 37378759
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Update on Extracellular Vesicle-Based Vaccines and Therapeutics to Combat COVID-19.
    Mustajab T; Kwamboka MS; Choi DA; Kang DW; Kim J; Han KR; Han Y; Lee S; Song D; Chwae YJ
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232549
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Minding the "T"s beyond the "B"s: Shaping vaccines for future pandemics.
    Kalimuddin S; Ooi EE
    PLoS Biol; 2023 Nov; 21(11):e3002351. PubMed ID: 37934720
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.